Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 19, 2015

Primary Completion Date

September 7, 2017

Study Completion Date

September 7, 2017

Conditions
Asthma
Interventions
BIOLOGICAL

Tralokinumab

Tralokinumab dose

OTHER

Placebo

Placebo dose

Trial Locations (51)

1070

Research Site, Brussels (Anderlecht)

1200

Research Site, Woluwé-St-Lambert

3000

Research Site, Leuven

3500

Research Site, Hasselt

9000

Research Site, Ghent

10461

Research Site, The Bronx

10717

Research Site, Berlin

10969

Research Site, Berlin

14618

Research Site, Rochester

15146

Research Site, Monroeville

19140

Research Site, Philadelphia

21001

Research Site, Vinnytsia

22299

Research Site, Hamburg

23225

Research Site, Richmond

27705

Research Site, Durham

29303

Research Site, Spartanburg

29621

Research Site, Anderson

30625

Research Site, Hanover

33604

Research Site, Pessac

33765

Research Site, Clearwater

38043

Research Site, Grenoble

44093

Research Site, Nantes

49007

Research Site, Dnipro

55131

Research Site, Mainz

59037

Research Site, Lille

60596

Research Site, Frankfurt

61002

Research Site, Kharkiv

61035

Research Site, Kharkiv

63141

Research Site, St Louis

69317

Research Site, Lyon

75246

Research Site, Dallas

75708

Research Site, Tyler

78006

Research Site, Boerne

78212

Research Site, San Antonio

80331

Research Site, München

81241

Research Site, München-Pasing

06520

Research Site, New Haven

1105 AZ

Research Site, Amsterdam

9728 NT

Research Site, Groningen

8934 AD

Research Site, Leeuwarden

43-360

Research Site, Bystra

31-011

Research Site, Krakow

31-209

Research Site, Krakow

90-141

Research Site, Lodz

59-300

Research Site, Lubin

27-400

Research Site, Ostrowiec Świętokrzyski

35-051

Research Site, Rzeszów

50-220

Research Site, Wroclaw

53-301

Research Site, Wroclaw

03680

Research Site, Kyiv

04201

Research Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY